Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2020 Apr;19(4):878-883.
doi: 10.1111/jocd.13122. Epub 2019 Sep 16.

The effect of 1540-nm fractional erbium-glass laser in the treatment of androgenic alopecia

Affiliations
Clinical Trial

The effect of 1540-nm fractional erbium-glass laser in the treatment of androgenic alopecia

Mohammed K Alhattab et al. J Cosmet Dermatol. 2020 Apr.

Abstract

Background: Androgenic alopecia is common, chronic dermatologic disorder. A variety of lasers and light sources appear to be safe and effective in the treatment of AGA.

Aims: To evaluate the efficacy and safety of 1540-nm fractional erbium glass laser in the treatment of AGA.

Patients/methods: This was an interventional therapeutic study for the treatment of patients with AGA. The patients received 10 sessions with 1540-nm fractional erbium glass laser at 2-week intervals. The assessment of the response was done before and at the end of follow-up period, both objectively (the change in the density of terminal hair and the diameter of the hair shaft) and subjectively (patient satisfaction). Any adverse effects were documented during the study.

Results: Forty-seven out of 51 patients completed the study. After 5 months of laser treatment, the density of hair and hair thickness was significantly increased in both males and females (P value .001).

Conclusion: The 1540-nm fractional erbium-glass laser seems to be an effective and safe option for treatment of patients with AGA. The improvement was accomplished in a short period.

Keywords: 1540 nm; androgenic alopecia; erbium-glass; fractional; laser.

PubMed Disclaimer

References

REFERENCES

    1. Messenger AG, De Berker D, Sinclair RD. Disorders of Hair. In: Burns DA, Breathnach SM, Cox NH, Griffiths C, eds. Rook’s Textbook of Dermatology (8th edn). Blackwell Publications; 2010:3383-3408.
    1. Soni VK. Androgenic alopecia: a counterproductive outcome of the anabolic effect of androgens. Med Hypotheses. 2009;73(3):420-426.
    1. Gan DC, Sinclair RD. Prevalence of male and female pattern hair loss in Maryborough. J Investig Dermatol Symp Proc. 2005;10(3):184-189.
    1. Ishino A, Uzuka M, Tsuji Y, Nakanishi J, Hanzawa N, Imamura S. Progressive decrease in hair diameter in Japanese with male pattern baldness. J. Dermatol. 1997;24(12):758-764.
    1. Sperling LC. Hair anatomy for the clinician. J Am Acad Dermatol. 1991;25(1 Pt 1):1-17.

Publication types

MeSH terms

LinkOut - more resources